EyePoint Pharmaceuticals
EYPT
EYPT
32 hedge funds and large institutions have $21.3M invested in EyePoint Pharmaceuticals in 2013 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 13 increasing their positions, 5 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
23% more funds holding
Funds holding: 26 → 32 (+6)
Holders
32
Holding in Top 10
–
Calls
$1.01M
Puts
$699K
Top Buyers
| 1 | +$3.17M | |
| 2 | +$1.15M | |
| 3 | +$1.15M | |
| 4 |
Renaissance Technologies
New York
|
+$809K |
| 5 |
Invesco
Atlanta,
Georgia
|
+$548K |
Top Sellers
| 1 | -$91K | |
| 2 | -$84.1K | |
| 3 | -$39K | |
| 4 |
BA
Bard Associates
Chicago,
Illinois
|
-$10.3K |
| 5 |
ECAM
East Coast Asset Management
Essex,
Massachusetts
|
-$7K |